Penserra Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Penserra Capital Management LLC

$4.61 Billion
Q3 2024

A detailed history of Penserra Capital Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Penserra Capital Management LLC holds 9 shares of REGN stock, worth $6,523. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 9 -0.0%

Holding current value

$6,523

Previous $9,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $439,610 - $483,761	-487 Reduced 98.19%	9 $8,000
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $106,974 - $121,674	-138 Reduced 21.77%	496 $434,000
Q3 2023 Nov 15, 2023	SELL	$692.45 - $844.37 $76,169 - $92,880	-110 Reduced 14.78%	634 $520,000
Q2 2023 Aug 11, 2023	BUY	$700.03 - $830.35 $481,620 - $571,280	688 Added 1228.57%	744 $533,000
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $32,470 - $35,253	-46 Reduced 45.1%	56 $40,000
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $49,361 - $62,291	86 Added 537.5%	102 $70,000
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $4.64 Million - $6.26 Million	-8,466 Reduced 99.81%	16 $9,000
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $2.86 Million - $3.35 Million	4,800 Added 130.36%	8,482 $5.92 Million
Q4 2021 Feb 15, 2022	BUY	$543.48 - $670.97 $2 Million - $2.47 Million	3,682 New	3,682 $2.33 Million
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $920,627 - $1.11 Million	-1,690 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $6.14 Million - $8.01 Million	-12,442 Reduced 88.04%	1,690 $1.05 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $4.75 Million - $6.99 Million	14,132 New	14,132 $6.9 Million
Q1 2019 May 08, 2019	SELL	$372.08 - $439.57 $3.33 Million - $3.93 Million	-8,948 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$335.82 - $403.04 $3 Million - $3.61 Million	8,948 New	8,948 $3.34 Million
Q3 2017 Oct 26, 2017	SELL	$431.38 - $504.0 $374,006 - $436,968	-867 Closed	0 $0
Q2 2017 Aug 21, 2017	BUY	N/A	867	867 $425,000

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $77.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Account

Penserra Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History